Study on kidney function info and bleeding risk with blood thinners
Part of Blood & lymphatic, Kidney & urinary clinical trials.
This study tests whether giving community pharmacists access to your kidney function can help reduce bleeding when you take direct oral anticoagulants (blood thinners). You may join if you have a prescription for these medications and visit a partner pharmacy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a prescription for a direct oral anticoagulant (blood thinner), either for the first time or a refill.
- You are 18 years or older.
- You go to one of the participating pharmacies to get your medication.
- You agree to be part of the study by signing a consent form.
- You are not pregnant or breastfeeding.
- You understand French.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how often bleeding happens in people with chronic kidney disease who are taking blood thinners (anticoagulants) for conditions like blood clots, mechanical heart valves, or atrial fibrillation (an irregular heartbeat). It aims to identify risk factors for bleeding to help doctors manage treatment more safely.
This trial compares two types of blood thinners (vitamin K antagonists and factor Xa inhibitors) versus no blood thinner in people with atrial fibrillation who are on dialysis or have very advanced kidney disease. It aims to see which option is safest and most effective for preventing strokes and bleeds.
This study looks at whether older adults with atrial fibrillation are taking the right dose of their blood thinner medicine. It aims to improve how doctors prescribe these medications in primary care.
This trial tests apixaban (a blood thinner) to prevent stroke in people with atrial fibrillation or atrial flutter who have very poor kidney function or are on dialysis. If you qualify, you may help researchers find a safer way to lower stroke risk for this higher-risk group.
This trial tests if talking with a pharmacist helps people with atrial fibrillation remember to take their blood thinner medicine correctly. It may improve stroke prevention.
This study compares two ways to manage atrial fibrillation (an irregular heartbeat) in people on dialysis. One approach uses a blood thinner called apixaban, and the other does not use blood thinners. The goal is to see which approach better prevents strokes and bleeding.
Hear when a new AOD Prescription trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.